HEADING 3002
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified:
Part of Chapter 30 — Pharmaceutical Products, Section VI.
Subheadings and tariff lines
3002D01Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes:
3002.12.00Antisera and other blood fractions
3002.12.00.10Human blood plasma
3002.12.00.20Normal human blood sera, whether or not freeze-dried
3002.12.00.30Human immune blood sera
3002.12.00.40Fetal Bovine Serum (FBS)
3002.12.00.90Other
3002.13.00Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
3002.13.00.10Monoclonal antibodies
3002.13.00.90Other
3002.14.00Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale
3002.14.00.10Containing monoclonal antibodies
3002.14.00.90Other
3002.15.00Immunological products, put up in measured doses or in forms or packings for retail sale
3002.15.00.11Containing monoclonal antibodies
3002.15.00.91Other
3002D02Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:
3002.41.00.00Vaccines for human medicine
3002.42.00.00Vaccines for veterinary medicine
3002.49.00Other
3002.49.00.10Ricin
3002.49.00.50Other
3002D03Cell cultures, whether or not modified:
3002.51.00.00Cell therapy products
3002.59.00.00Other
3002.90Other:
3002.90.10.00Ferments
3002.90.52Other
3002.90.52.10Whole human blood
3002.90.52.20Antiallergenic preparations
3002.90.52.50Other
Recent CBP rulings on heading 3002
N350948
December 18, 2025
The tariff classification of HEC88473 Drug Product (also known as APL-18881) in dosage form, from China
N351298
August 12, 2025
The tariff classification of Lentiviral Vector from China
N343343
November 4, 2024
The tariff classification of Poliomyelitis Vaccine inactivated monovalent types 1, 2 and 3 from France
N335649
October 18, 2023
The tariff classification of Hyrimoz® (adalimumab-adaz) Injection in dosage form, from Austria
N333558
June 27, 2023
The tariff classification of ELOCTATE® [Antihemophilic factor (recombinant), Fc fusion protein] in dosage form, from the United States
N331005
March 7, 2023
The tariff classification of clinical trial kits from the United States
N325758
May 25, 2022
The tariff classification of YESCARTA® (Axicabtagene Ciloleucel) from the Netherlands
H323683
March 17, 2022
Request for Internal Advice on Protest No. 3002-21-103869; U.S. International Trade Commission; General Exclusion Order; Investigation No. 337-TA-567, Certain Foam Footwear
N320317
July 28, 2021
The tariff classification of glycerol stock of Escherichia coli (E. coli) from China
N319434
June 9, 2021
The tariff classification of Recombinant Adeno-associated virus (AAV) packed for retail sale from China
N319161
May 27, 2021
The tariff classification of Recombinant Lentivirus packed for retail sale from China, the United Kingdom and the European Union countries
N319149
May 27, 2021
The tariff classification of ADSTILADRIN® (nadofaragene firadenovec-nrpl) in dosage form and a demonstration unit for Adstiladrin from Finland
Classifying products under 3002?
TariffLens picks the right 10-digit code with GRI reasoning and cited rulings.
Book a demo →